FLT3 and acute myeloid leukemia: FST expression was suppressed by pharmacologic inhibition of CREB both in an isogenic Ba/F3‐FLT3/ITD cell model and in FLT3/ITD AML patients treated with a specific FLT3 inhibitor quizartinib.